A study has shown that breast cancer patients who take aromatase inhibitors, a common breast cancer medication, will find semagludtides dont work for themwhich is unfortunate, since those meds cause weight gain
Its about changing the trajectory of metabolic health before damage occurs. Metabolic Therapeutics Oral semaglutide was just approved for weight loss by the FDA, and now it looks like the small-molecule, nonpeptide oral GLP-1RA orforglipron isnt far behind it
Neuropathology 20, 822
Conjaerts SHP, Bruijnes JE, Beerhorst K, Beekman R
doi: 10.3390/ijms242015430, 111 QuS.LinH.PfeifferN.GrusF
Alli contains the same active ingredient as orlistat, but uses a lower dose 60mg rather than 120mg